These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2961227

  • 1. The influence of thymic preparations on natural cytotoxicity of human monocytes.
    Szkaradkiewicz A.
    Allerg Immunol (Leipz); 1987; 33(3):169-73. PubMed ID: 2961227
    [Abstract] [Full Text] [Related]

  • 2. Studies on natural cytotoxicity of human monocytes in viral hepatitis.
    Kiczka W, Szkaradkiewicz A, Flieger J.
    Immunol Lett; 1985; 9(2-3):87-91. PubMed ID: 3988320
    [Abstract] [Full Text] [Related]

  • 3. Natural killer activity in patients with acute viral hepatitis.
    Chemello L, Mondelli M, Bortolotti F, Schiavon E, Pontisso P, Alberti A, Rondanelli EG, Realdi G.
    Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650
    [Abstract] [Full Text] [Related]

  • 4. Studies on pokeweed mitogen-induced lymphocyte proliferation in viral hepatitis.
    Szkaradkiewicz A, Kiczka W, Trejster E.
    Arch Immunol Ther Exp (Warsz); 1983 Apr; 31(4):505-9. PubMed ID: 6686929
    [Abstract] [Full Text] [Related]

  • 5. Natural killer activity in patients with biopsy-proven liver disease.
    Serdengecti S, Jones DB, Holdstock G, Wright R.
    Clin Exp Immunol; 1981 Aug; 45(2):361-4. PubMed ID: 7318258
    [Abstract] [Full Text] [Related]

  • 6. [The interferon system and natural cytotoxicity functions in patients with acute viral hepatitis A and B].
    Kaverina OV, Chernova LG, Fabrikov AP, Malinovskaia VV, Kasimova NB, Karpenko SF, Sluvko EI, Cherenova OP.
    Ter Arkh; 1994 Aug; 66(2):7-9. PubMed ID: 7512755
    [No Abstract] [Full Text] [Related]

  • 7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the mononuclear cell infiltrate in piecemeal necrosis.
    Alexander G, Williams R.
    Lab Invest; 1984 Mar; 50(3):247-9. PubMed ID: 6366361
    [No Abstract] [Full Text] [Related]

  • 9. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer.
    Strayer DR, Carter WA, Mayberry SD, Pequignot E, Brodsky I.
    Cancer Res; 1984 Jan; 44(1):370-4. PubMed ID: 6690050
    [Abstract] [Full Text] [Related]

  • 10. Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes.
    Dienstag JL, Bhan AK.
    J Immunol; 1980 Nov; 125(5):2269-76. PubMed ID: 6159404
    [No Abstract] [Full Text] [Related]

  • 11. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T, Sone S.
    J Immunol; 1986 Feb 01; 136(3):1117-22. PubMed ID: 3079797
    [Abstract] [Full Text] [Related]

  • 12. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P, Gips CH, Huizenga JR, van der Waart M, Schuurs A.
    Hepatogastroenterology; 1980 Oct 01; 27(5):350-5. PubMed ID: 7203369
    [Abstract] [Full Text] [Related]

  • 13. [Immunologic aspects of acute viral hepatitis at different ages].
    Botsvadze ESh, Katsitadze TK, Kvitashvili AA, Vashakidze ET.
    Ter Arkh; 1986 Oct 01; 58(2):55-9. PubMed ID: 3704939
    [Abstract] [Full Text] [Related]

  • 14. Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.
    Weiner LM, Steplewski Z, Koprowski H, Litwin S, Comis RL.
    Cancer Res; 1988 Feb 15; 48(4):1042-6. PubMed ID: 3123051
    [Abstract] [Full Text] [Related]

  • 15. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
    Onozaki K, Matsushima K, Kleinerman ES, Saito T, Oppenheim JJ.
    J Immunol; 1985 Jul 15; 135(1):314-20. PubMed ID: 3873493
    [Abstract] [Full Text] [Related]

  • 16. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET, Babbitt JT, Kawakami K.
    J Immunol; 1986 Jul 01; 137(1):172-8. PubMed ID: 3711665
    [Abstract] [Full Text] [Related]

  • 17. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
    Mavier P, Edgington TS.
    J Immunol; 1984 Apr 01; 132(4):1980-6. PubMed ID: 6321594
    [Abstract] [Full Text] [Related]

  • 18. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF, Houthoff HJ, Huitema S, Wolters G, Poppema S, Gips CH.
    Clin Exp Immunol; 1984 Apr 01; 56(1):121-8. PubMed ID: 6713726
    [Abstract] [Full Text] [Related]

  • 19. Abnormal T-cell activation in chronic hepatitis B viral infection: a consequence of monocyte dysfunction?
    Nouri-Aria KT, Magrin S, Alexander GJ, Anderson MG, Williams R, Eddleston AL.
    Immunology; 1988 Aug 01; 64(4):733-8. PubMed ID: 2971612
    [Abstract] [Full Text] [Related]

  • 20. [Effect of interferon on clinico-laboratory indicators in patients with acute viral hepatitis B].
    Pokrovskiĭ VI, Zmyzgova AV, Matveeva SM, Saltykov VP, Soibnazarov ISh.
    Ter Arkh; 1986 Aug 01; 58(10):29-32. PubMed ID: 3798344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.